yourpalVal

VINC breaking out soon?

看多
NASDAQ:VINC   Vincerx Pharma, Inc.
Very little to be found on this one fundamentally, as to what the catalyst could be.
But SEC forms show numerous insiders (including CEO) buying before Christmas. Today, analyst Geulah Livshits from Chardan Capital released a buy rating with a PT of 33.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。